how does glp 1 affect pancreas Science Behind GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements Secretion of GLP-1 from the

Whilst these medications offer significant benefits when combined with lifestyle changes, questions persist about potential adverse effects, including pancreatitis

In fact her boss, Mads Krogsgaard Thomsen, remembers that top management gave them only one year 'to come up with a GLP-1 candidate for daily administration to people with type 2 diabetes' (Holst 2024)

There are several phase 3 trials evaluating GLP-1s for indications, such as metabolic dysfunction-associated steatohepatitis (MASH), prediabetes, Alzheimer's disease, diabetic retinopathy, and osteoarthritis of the knee (in patients with obesity)

Alkhedhairi SA, Aba Alkhayl FF, Ismail AD, Rozendaal A, German M, MacLean B, et al